Cancer Trials Scarce in Black Communities

Access to cutting-edge cancer treatments through clinical trials is not equally distributed across the United States. New research published in JAMA Network Open reveals a stark reality: counties with higher social vulnerability, where Black people and especially Black women are more likely to reside, have significantly less access to cancer clinical trials.

The Link Between Social Vulnerability and Trial Access

The study, led by Dr. Rishi Robert Sekar from the University of Michigan, examined the connection between social determinants of health (SDOH) and the availability of cancer clinical trials across 3,142 U.S. counties. Researchers found that counties with the highest Social Vulnerability Index (SVI) scores were considerably less likely to host any cancer clinical trials compared to the least vulnerable counties. Specifically, only 49.6% of the most vulnerable counties had trials, versus 70.0% of the least vulnerable.

Furthermore, these highly vulnerable counties had fewer population-adjusted trials available (223.4 compared to 579.2 in less vulnerable areas). These disparities remained consistent across different SVI quintiles, indicating a systemic issue where communities facing greater social and economic challenges have fewer opportunities to participate in potentially life-saving research.

Implications for Black Communities and Cancer Survival

This lack of access has serious implications for Black communities, particularly concerning cancer survival rates. Clinical trials offer participants early access to novel therapies that may not yet be widely available but could significantly improve outcomes. For Black women, who already face higher mortality rates from breast cancer than white women, even at similar diagnosis stages, participation in trials is crucial.

By including Black participants in clinical trials, researchers gain vital insights into how different populations respond to treatments. This data is essential for developing more equitable and effective cancer care strategies tailored to diverse patient groups. Participating in trials allows Black women to directly contribute to the advancement of treatments that could benefit future generations.

A Call for Equitable Access and Support

The study’s authors stress the importance of identifying and supporting socially vulnerable communities to expand trial opportunities. They advocate for counselors to recognize that Black women with disabilities are eager to participate in the labor market and view self-employment as a viable path. Understanding how vocation impacts overall well-being and addressing systemic barriers are critical steps toward ensuring equitable cancer care for all.